News

Filter

Current filters:

RebifEnbrel

1 to 9 of 12 results

Fillip for Biogen as FDA sets no new trial requirement for Amevive

24-06-2002

Biogen moved a step closer towards US approval of its new treatment formoderate-to-severe chronic plaque…

AlefaceptAmeviveAvonexEfalizumabEnbreletanerceptGenentechinfliximabInterferon beta-1aJohnson & JohnsonRaptivaRebifRemicade

Serono "almost perfect biotech investment"

10-03-2000

Analysts at Morgan Stanley Dean Witter have initiated coverage of Swissgroup Ares-Serono with a strong…

Antihemophilic FactorAvonexCoagulation Factor VIIaEnbreletanerceptFollistim AQFollitropin AlfaFollitropin BetaGonal-FInterferon beta-1aOrganonRebifRecombinant

1 to 9 of 12 results

COMPANY SPOTLIGHT

Menarini

Back to top